Molecular imaging and nuclear medicine: Expectations and requirements

MedicaMundi

Volumn 47, Issue 1, 2003, Pages 10-16

  Rollo, F D ^a  

^a PHILIPS HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 18844411345     PISSN: 00257664     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Wick RA. Photon Counting Imaging: Applications in Biomedical Research. Biotechniques 1989; 3: 262-269.
2. Hooper CE, Ansorge RE, Browne HM et al. CCD Imaging of Luciferase Gene Expression in Single Mammalian Cells. J Biolumin Chemilumin 1990; 5: 123-130.
3. Tjuvajev JG, Finn R, Watanabe K et al. Noninvasive Imaging of Herpes Virus Thymidine Kinase Gene Transfer and Expression: A Potential Method for Monitoring Clinical Gene Therapy. Cancer Res 1996; 56: 4087-4095.
4. Tjuvajev JG, Avril N, Oku T et al. Imaging Herpes Virus Thymidine Kinase Gene Transfer and Expression by Positron Emission Tomography. Cancer Res 1998; 58: 4333-4341.
5. Gambhir SS, Barrio JR, Wu I et al. Imaging of Adenoviral-Directed Herpes Simplex Virus Type I Thymodine Kinase Reporter Gene Expression in Mice with Radiolabeled Ganciclovir. J Nucl Med 2003; 11: 2003-2011.
6. Gambhir SS, Barrio JR, Phelps ME et al. Imaging Adenoviral-Directed Reporter Gene Expression in Living Animals with PET. Proc Natl Acad Sci USA 1999; 5: 2333-2338.
7. Editorial: Molecular Imaging. ACR 2000; 56,6: 25-30.
8. Del Vecchio S, Ciarmiello A, Pace L et al. Fractional Retention of Tc-99m Sestamibe as an Index of P-glycoprotein Expression in Untreated Breast Cancer Patients. J Nucl Med 1997; 38: 1348-1351.
9. Tan B, Piwnica-Worms D, Ratner L. Multidrug Resistance Transporters and Modulation. Curr Opin Oncol 2000; 12: 450-458.
10. Blankenberg FG, Katsikis PD, Tait JF et al. In Vivo Detection and Imaging of Phosphatidylserine Expression During Programmed Cell Death. Proc Natl Acad Sci USA 1998; 95: 6349-6354.
11. Stumpe KD, Urbinelli M, Steinert HC et al. Whole Body Positron Emission Tomography using Fluorodeoxyglucose for Staging of Lymphoma: Effectiveness and Comparison with Computed Tomography. Eur J Nucl Med 1998; 25: 721-728.
12. Newman JS, Francis IR, Kaminski MS et. al. Imaging of Lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 1994; 190: 111-116.
13. Witzig TE, Flinn IW, Gordon LI et al. Treatment with Ibritumomab Tiuxetan Radioimmunotherapy in Patients with Rituximab-Refractory Follicular Non-Hodgkin's Lymphoma. J Clin Oncol 2002; 20: 3262-3269.
14. Kaiser CP. PET/CT Fusion Proves Its Value. Diagnostic Imaging 2002; June: 56-65.
15. Serganova I, Ponomarev V, Doubrovin M et al. Imaging TGF-B Signal Transduction Pathway Activity with PET. J Nucl Med 2002; 43: 69P.
16. Brice J. Molecular Imaging Transports Diagnosis to the Next Level. Diagnostic Imaging; July 2001: 8-15.